18. September 2025 | Briefing
Revision of the Therapeutic Products Act
(TPA): Increased Medication Safety and
Advanced Therapy Medicinal Products
18. September 2025 | Briefing
Revision of the Therapeutic Products Act
(TPA): Increased Medication Safety and
Advanced Therapy Medicinal Products
On 3 September 2025, the Federal Council adopted the dispatch[AM1] regarding the partial revision of the Therapeutic Products Act (TPA) for submission to Parliament. The objectives are to: (i) promote digitalisation in the areas of prescription, dispensing, and use of therapeutic products, (ii) enhance medicinal product safety in paediatrics, (iii) regulate access to medicinal products for novel therapies, and (iv) establish broad equivalence with EU law concerning veterinary medicinal products.
